Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/23/2010WO2010148191A2 Compositions and methods for cyclofructans as separation agents
12/23/2010WO2010148190A1 Aqueous pharmaceutical compositions containing borate-polyol complexes
12/23/2010WO2010148179A1 Method of treating a disorder associated with mtp
12/23/2010WO2010148177A2 Compounds, compositions, methods of synthesis, and methods of treatment
12/23/2010WO2010148138A2 Camptothecin derivatives
12/23/2010WO2010148094A1 Methods and compositions for increasing trichogenic potency of dermal cells
12/23/2010WO2010148074A1 The use of metabotropic glutamate receptor potentiators for reducing nicotine dependence
12/23/2010WO2010148065A2 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
12/23/2010WO2010148053A1 Ectoparasiticidal methods and formulations
12/23/2010WO2010148050A2 Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
12/23/2010WO2010148042A1 Oxabicyclo [4.1.o]hept-b-en-s-ylcarbamoyl derivatives inhibiting the nuclear factor-kappa(b) - (nf-kb)
12/23/2010WO2010148040A1 Modulation of systemic exposure to rifaximin
12/23/2010WO2010148013A2 Lipid formulated dsrna targeting the pcsk9 gene
12/23/2010WO2010148012A2 Hemostatic material and delivery device
12/23/2010WO2010148007A2 Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
12/23/2010WO2010148006A1 Hepatitis c virus inhibitors
12/23/2010WO2010147978A1 Dosage forms of apixaban
12/23/2010WO2010147975A1 Gamma secretase modulators
12/23/2010WO2010147973A1 Gamma secretase modulators
12/23/2010WO2010147962A1 Choline esters
12/23/2010WO2010147957A2 Dithiol compounds, derivatives, and uses therefor
12/23/2010WO2010147938A2 Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
12/23/2010WO2010147922A1 Deuterated i soindoline- i, 3-dione derivatives as pde4 and tnf-alpha inhibitors
12/23/2010WO2010147917A1 Disubstituted phthalazine hedgehog pathway antagonists
12/23/2010WO2010147899A1 Stable nanoparticulate drug suspension
12/23/2010WO2010147898A2 Small molecule inhibitors of spleen tyrosine kinase (syk)
12/23/2010WO2010147836A1 Combination therapies using antibacterial aminoglycoside compounds
12/23/2010WO2010147830A2 Aminothiazole modulators of beta-3-adrenoreceptor
12/23/2010WO2010147792A2 Compounds which selectively modulate the cb2 receptor
12/23/2010WO2010147776A1 Substituted -1,3,8-triazaspiro[4.5]decane-2,4-diones
12/23/2010WO2010147768A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
12/23/2010WO2010147666A1 Compounds useful as carbonic anhydrase modulators and uses thereof
12/23/2010WO2010147665A1 Treatment of multiple sclerosis with laquinimod
12/23/2010WO2010147653A1 Opsin-binding ligands, compositions and methods of use
12/23/2010WO2010147631A1 Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders
12/23/2010WO2010147612A1 Methods of modulating cell regulation by inhibiting p53
12/23/2010WO2010147472A1 Inhibition of nfk-b mediated virus replication with specific oligosaccharides
12/23/2010WO2010147456A1 Inhibition of nfk-b mediated virus replication with specific oligosaccharides
12/23/2010WO2010147434A2 Use of toosendanin or melia azedarach extracts for preventing or treating dementia
12/23/2010WO2010147430A2 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical composition comprising same
12/23/2010WO2010147387A2 Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides as active ingredients
12/23/2010WO2010147302A2 Novel intermediates of voriconazole and preparation method of voriconazole using the same
12/23/2010WO2010147274A1 Secretory granules and granulogenic factors as a target for cancer treatment
12/23/2010WO2010147238A1 Agent for preventing or treating abnormality in skin water permeation function
12/23/2010WO2010147234A1 Diarylamide-spirodiamine derivative
12/23/2010WO2010147184A1 Prophylactic and/or therapeutic agent for dysmenorrhea
12/23/2010WO2010147169A1 Pharmaceutical composition having improved solubility
12/23/2010WO2010147165A1 Rna virus infection inhibitor, method for inhibition of infection by rna virus, products for inhibition of infection by rna virus, and use as rna virus infection inhibitor
12/23/2010WO2010147144A1 Oral liquid preparation
12/23/2010WO2010147138A1 Gene encoding fatty acid elongase, and use thereof
12/23/2010WO2010147133A1 Novel imidazopyridine compound
12/23/2010WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof
12/23/2010WO2010147068A1 Substituted polycyclic carbamoylpyridone derivative
12/23/2010WO2010146881A1 Substituted isoquinoline derivative
12/23/2010WO2010146872A1 Composition for external application comprising aripiprazole and organic acid as active ingredients
12/23/2010WO2010146831A1 Prenatal milk-derived composition for preventing the risk of low birthweight of newborns
12/23/2010WO2010146788A1 Apigenin-containing composition
12/23/2010WO2010146606A1 Nanodispersion of a drug and process for its preparation
12/23/2010WO2010146605A1 Novel gpr 119 agonists
12/23/2010WO2010146601A1 Rapid dissolvable oral film for delivering herbal extract/s with or without other pharmaceutically active agents
12/23/2010WO2010146597A1 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
12/23/2010WO2010146585A1 Tellurium-containing compounds for treating viral infections
12/23/2010WO2010146568A2 Bifidobacteria for treating diabetes and related conditions
12/23/2010WO2010146536A1 Suspension of particles with drug
12/23/2010WO2010146488A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010WO2010146478A1 Parenteral composition comprising a fluoroquinolone compound and a nitroimidazole compound
12/23/2010WO2010146414A1 Influenza vaccine, composition, and methods of use
12/23/2010WO2010146407A1 Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
12/23/2010WO2010146406A1 Nanoparticulate telmisartan compositions and process for the preparation thereof
12/23/2010WO2010146404A1 Adamantane derivatives of aza-crown ethers and their use in treatment of tumor
12/23/2010WO2010146395A1 Pyrazine carboxamides as inhibitors of dgat1
12/23/2010WO2010146394A1 Theobromine for the treatment of cough
12/23/2010WO2010146351A1 Indolylmethyl-morpholine derivatives as kinase inhibitors
12/23/2010WO2010146348A2 New crystalline form of pemirolast
12/23/2010WO2010146341A2 New crystalline form of pemirolast
12/23/2010WO2010146338A1 Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders
12/23/2010WO2010146299A1 Azetidine-derived esters, preparation thereof, and therapeutic use thereof as cannabinoid receptor modulators
12/23/2010WO2010146257A1 Connection device for a submersible connector
12/23/2010WO2010146236A1 Urea substituted sulphonamide derivatives
12/23/2010WO2010146215A1 Composition for preventing or treating medical disorders associated with angiogenesis and cell proliferation
12/23/2010WO2010146187A2 Process for the preparation of telmisartan
12/23/2010WO2010146179A2 Solid pharmaceutical composition comprising rivaroxaban
12/23/2010WO2010146173A1 Quinazoline derivatives as histamine h4-recept0r inhibitors for use in the treatment of inflammatory disorders
12/23/2010WO2010146133A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010WO2010146132A1 Sulfonamides and sulfamides as zap-70 inhibitors
12/23/2010WO2010146125A1 Ester derivatives as competitive inhibitors of type ii dehydroquinase enzyme
12/23/2010WO2010146113A1 Antifungal 1, 2, 4-triazolyl derivatives having a 5- sulfur substituent
12/23/2010WO2010146112A1 Antifungal 1, 2, 4-triazolyl derivatives
12/23/2010WO2010146111A1 Antifungal 1, 2, 4-triazolyl derivatives
12/23/2010WO2010146105A1 S1p1 agonists comprising a bicyclic n-containing ring
12/23/2010WO2010146104A1 Thiadiazole derivatives and their use for the treatment of disorders mediated by slpl receptors
12/23/2010WO2010146083A1 Anthelmintic agents and their use
12/23/2010WO2010146078A2 Novel uses of hydroxyproline compositions
12/23/2010WO2010146055A1 Antagonists of beta-catenin for preventing and/or treating neurodegenerative disorders
12/23/2010WO2010146025A1 Tricyclic azabicyclo [4.1.0] heptane derivatives as inhibitors of serotonin, dopamine and norepinephrine re-uptake
12/23/2010WO2010145998A1 Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
12/23/2010WO2010145989A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
12/23/2010WO2010145903A1 New therapeutical uses of inecalcitol
12/23/2010WO2010145883A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/23/2010WO2010145800A1 Salts of tramadol and diflunisal and their crystal form in the treatment of pain
1 ... 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 ... 7860